1079 related articles for article (PubMed ID: 17133543)
1. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.
Brown AK; Quinn MA; Karim Z; Conaghan PG; Peterfy CG; Hensor E; Wakefield RJ; O'Connor PJ; Emery P
Arthritis Rheum; 2006 Dec; 54(12):3761-73. PubMed ID: 17133543
[TBL] [Abstract][Full Text] [Related]
2. Patients with rheumatoid arthritis in clinical remission manifest persistent joint inflammation on histology and imaging studies.
Anandarajah A; Thiele R; Giampoli E; Monu J; Seo GS; Feng C; Ritchlin CT
J Rheumatol; 2014 Nov; 41(11):2153-60. PubMed ID: 25274900
[TBL] [Abstract][Full Text] [Related]
3. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
Wechalekar MD; Lester S; Proudman SM; Cleland LG; Whittle SL; Rischmueller M; Hill CL
Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
[TBL] [Abstract][Full Text] [Related]
4. Association of bone edema with the progression of bone erosions quantified by hand magnetic resonance imaging in patients with rheumatoid arthritis in remission.
Lisbona MP; Pàmies A; Ares J; Almirall M; Navallas M; Solano A; Maymó J
J Rheumatol; 2014 Aug; 41(8):1623-9. PubMed ID: 24986851
[TBL] [Abstract][Full Text] [Related]
5. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis.
Brown AK; Conaghan PG; Karim Z; Quinn MA; Ikeda K; Peterfy CG; Hensor E; Wakefield RJ; O'Connor PJ; Emery P
Arthritis Rheum; 2008 Oct; 58(10):2958-67. PubMed ID: 18821687
[TBL] [Abstract][Full Text] [Related]
6. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?
Janta I; Valor L; De la Torre I; Martínez-Estupiñán L; Nieto JC; Ovalles-Bonilla JG; Martínez-Barrio J; Bello N; Hinojosa M; Montoro M; González CM; López-Longo J; Monteagudo I; Carreño L; Naredo E
Rheumatol Int; 2016 Mar; 36(3):387-96. PubMed ID: 26712373
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints.
Picchianti Diamanti A; Navarini L; Messina F; Markovic M; Arcarese L; Basta F; Meneguzzi G; Margiotta DPE; Laganà B; Afeltra A; D'Amelio R; Iagnocco A
Clin Exp Rheumatol; 2018; 36(6):984-989. PubMed ID: 29998842
[TBL] [Abstract][Full Text] [Related]
9. ACR/EULAR Definitions of Remission Are Associated with Lower Residual Inflammatory Activity Compared with DAS28 Remission on Hand MRI in Rheumatoid Arthritis.
Lisbona MP; Solano A; Ares J; Almirall M; Salman-Monte TC; Maymó J
J Rheumatol; 2016 Sep; 43(9):1631-6. PubMed ID: 27370881
[TBL] [Abstract][Full Text] [Related]
10. Effects of double filtration plasmapheresis, leflunomide, and methotrexate on inflammatory changes found through magnetic resonance imaging in early rheumatoid arthritis.
Yu X; Wang L; Xu P; Lu W; Lan G; Ping L; Wang X; Tian J; Liu J
J Rheumatol; 2012 Jun; 39(6):1171-8. PubMed ID: 22505700
[TBL] [Abstract][Full Text] [Related]
11. Ultrasonography is a potent tool for the prediction of progressive joint destruction during clinical remission of rheumatoid arthritis.
Yoshimi R; Hama M; Takase K; Ihata A; Kishimoto D; Terauchi K; Watanabe R; Uehara T; Samukawa S; Ueda A; Takeno M; Ishigatsubo Y
Mod Rheumatol; 2013 May; 23(3):456-65. PubMed ID: 22802010
[TBL] [Abstract][Full Text] [Related]
12. Investigation of a multi-biomarker disease activity score in rheumatoid arthritis by comparison with magnetic resonance imaging, computed tomography, ultrasonography, and radiography parameters of inflammation and damage.
Krabbe S; Bolce R; Brahe CH; Døhn UM; Ejbjerg BJ; Hetland ML; Sasso EH; Chernoff D; Hansen MS; Knudsen LS; Hansen A; Madsen OR; Hasselquist M; Møller J; Østergaard M
Scand J Rheumatol; 2017 Sep; 46(5):353-358. PubMed ID: 27682742
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression.
Naredo E; Collado P; Cruz A; Palop MJ; Cabero F; Richi P; Carmona L; Crespo M
Arthritis Rheum; 2007 Feb; 57(1):116-24. PubMed ID: 17266071
[TBL] [Abstract][Full Text] [Related]
14. MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis.
Forslind K; Svensson B
Scand J Rheumatol; 2016; 45(2):99-102. PubMed ID: 26313244
[TBL] [Abstract][Full Text] [Related]
15. Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trial.
Møller-Bisgaard S; Hørslev-Petersen K; Ejbjerg BJ; Boesen M; Hetland ML; Christensen R; Møller J; Krogh NS; Stengaard-Pedersen K; Østergaard M
Trials; 2015 Apr; 16():178. PubMed ID: 25896862
[TBL] [Abstract][Full Text] [Related]
16. Presence of power Doppler synovitis in rheumatoid arthritis patients with synthetic and/or biological disease-modifying anti-rheumatic drug-induced clinical remission: experience from a Chinese cohort.
Geng Y; Han J; Deng X; Zhang Z
Clin Rheumatol; 2014 Aug; 33(8):1061-6. PubMed ID: 24777468
[TBL] [Abstract][Full Text] [Related]
17. Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission.
Terslev L; Brahe CH; Østergaard M; Fana V; Ammitzbøll-Danielsen M; Møller T; Krabbe S; Hetland ML; Døhn UM
Arthritis Res Ther; 2021 Feb; 23(1):48. PubMed ID: 33522948
[TBL] [Abstract][Full Text] [Related]
18. Synovitis and osteitis are very frequent in rheumatoid arthritis clinical remission: results from an MRI study of 294 patients in clinical remission or low disease activity state.
Gandjbakhch F; Conaghan PG; Ejbjerg B; Haavardsholm EA; Foltz V; Brown AK; Møller Døhn U; Lassere M; Freeston J; Bøyesen P; Bird P; Fautrel B; Hetland ML; Emery P; Bourgeois P; Hørslev-Petersen K; Kvien TK; McQueen F; Ostergaard M
J Rheumatol; 2011 Sep; 38(9):2039-44. PubMed ID: 21885514
[TBL] [Abstract][Full Text] [Related]
19. Does ultrasound-scored synovitis depend on the pharmacokinetics of subcutaneous anti-TNF agents in patients with rheumatoid arthritis?
Naredo E; Hinojosa M; Valor L; Hernández-Flórez D; Mata-Martínez C; Serrano-Benavente B; Del Río T; Bello N; Montoro M; Nieto-González JC; González CM; López-Longo FJ; Monteagudo I; Carreño L
Rheumatology (Oxford); 2014 Nov; 53(11):2088-94. PubMed ID: 24939676
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow oedema predicts structural progression in a 1-year follow-up of 85 patients with RA in remission or with low disease activity with low-field MRI.
Gandjbakhch F; Foltz V; Mallet A; Bourgeois P; Fautrel B
Ann Rheum Dis; 2011 Dec; 70(12):2159-62. PubMed ID: 21859693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
